STAT3 and neoplasm: Emerging evidence highlights that STAT3 hyperactivation occurs not only in tumor cells but also in immune cells infiltrating the tumor microenvironment (TME) (138), affecting a broad spectrum of immune populations, including macrophages (139), T cells (140, 141), NK cells (142), and dendritic cells (143).